The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir.
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Research Abstract Details
The best strategy for control of cytomegalovirus (CMV) infection in lung transplant patients is still not determined. The aim of this study was to document the incidence of CMV infection in a cohort of lung transplant recipients under universal prophylaxis with intravenous ganciclovir. All patients received immunosuppressive regimens consisting of cyclosporine, azathioprine, and prednisone. Regardless of CMV serostatus, intravenous ganciclovir was prescribed for every patient in the first 3 months post-transplantation. CMV infection was defined as the detection of CMV pp65 in leukocytes. Eighty-two lung transplant patients were included over a 5-year period. The incidence of CMV infection in the first year post-transplantation was 68.3%, occurring after a median length of 114 days (range, 26-343 days). This study revealed a high incidence of CMV infection in the first year following lung transplantation despite prolonged universal ganciclovir prophylaxis.
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Publishing Authors By Initials
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: The Brazilian journal of infectious diseases : an
VOLUME: 11
Page Numbers: 212-4
Journal Abbreviation: Braz J Infect Dis
ISSN: 1413-8670
DAY: 12
MONTH: Apr
YEAR: 2007
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9812937
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir.
AFFILIATION: Laboratory of Transplant Immunology, Santa Casa Complexo Hospitalar, Avenida Independência 75, 94035-075 Porto Alegre, RS, Brazil. regina@santacasa.tch.br
Country: Brazil
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Braz J Infect Dis
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir Related Publications